SciNeuro
SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration – neurovascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimer’s disease, Parkinson’s disease, and other devastating CNS diseases.
Tech Stack (23 technologies)
Frequently Asked Questions
What technologies does SciNeuro use?+
SciNeuro uses 23 technologies including Bootstrap, WP Rocket, WordPress.
What industry is SciNeuro in?+
SciNeuro operates in the Biopharma industry.
Where is SciNeuro based?+
SciNeuro is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026